FY2025 report accounts for 226,212.39 more than it received

The FY2025 report certifies 638,208.69 received since 2022, interest included (p1, Q3). On the same page it certifies 12,770.28 expended (Q6), 262,229.72 appropriated or encumbered but not yet spent (Q7) and 589,421.08 unspent or uncommitted on hand (Q9). Those three figures add to 864,421.08, which is 226,212.39 more than the report says was ever received. The on hand figure is 638,208.69 less the 36,017.33 of interest the report lists at Q2, less the 12,770.28 spent. It leaves out the interest and does not deduct the encumbrance it certifies. The books show 12,770.28 paid through 06/30/2025, seven payroll lines of 02/28/2025 to 05/09/2025, and no open order on any opioid account. By the report's own receipts that leaves 625,438.41 unspent and uncommitted at 06/30/2025. The report cannot certify both its encumbrance and its on hand figure from 638,208.69.